Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A Burger

Showing results (41-50 of 223) with videos related to

Pageof 23
Sort By:
Blood|November 5, 2005
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironmentJan A Burger, Thomas J Kipps
Expert Opinion on Investigational Drugs|November 11, 2017
Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL)Philip A Thompson, Jan A Burger
Leukemia & Lymphoma|February 22, 2013
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)Jan A Burger, Joseph J Buggy
Seminars in Cancer Biology|September 28, 2011
The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapiesJan A Burger, Richard J Ford
Cancer Research|May 27, 2010
BCR-mediated decrease of CXCR4 and CD62L in CLLMaite P Quiroga, Jan A Burger
Blood|February 4, 2017
HSP90, a chaperone that can make you SYKElisa Ten Hacken, Jan A Burger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Molecular pathways: targeting the microenvironment in chronic lymphocytic leukemia--focus on the B-cell receptorElisa ten Hacken, Jan A Burger
Expert Opinion on Investigational Drugs|April 2, 2009
CXCR4 chemokine receptor antagonists: perspectives in SCLCJan A Burger, David J Stewart
Seminars in Cancer Biology|September 11, 2013
The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapiesJan A Burger, John G Gribben
Open Journal of Hematology|July 31, 2012
Cell Trafficking in Chronic Lymphocytic LeukemiaMatthew S Davids, Jan A Burger
Pageof 23

Showing results (41-50 of 223) with videos related to

Sort By:
Pageof 23
Blood|November 5, 2005
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironmentJan A Burger, Thomas J Kipps
Expert Opinion on Investigational Drugs|November 11, 2017
Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL)Philip A Thompson, Jan A Burger
Leukemia & Lymphoma|February 22, 2013
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765)Jan A Burger, Joseph J Buggy
Seminars in Cancer Biology|September 28, 2011
The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapiesJan A Burger, Richard J Ford
Cancer Research|May 27, 2010
BCR-mediated decrease of CXCR4 and CD62L in CLLMaite P Quiroga, Jan A Burger
Blood|February 4, 2017
HSP90, a chaperone that can make you SYKElisa Ten Hacken, Jan A Burger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2013
Molecular pathways: targeting the microenvironment in chronic lymphocytic leukemia--focus on the B-cell receptorElisa ten Hacken, Jan A Burger
Expert Opinion on Investigational Drugs|April 2, 2009
CXCR4 chemokine receptor antagonists: perspectives in SCLCJan A Burger, David J Stewart
Seminars in Cancer Biology|September 11, 2013
The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapiesJan A Burger, John G Gribben
Open Journal of Hematology|July 31, 2012
Cell Trafficking in Chronic Lymphocytic LeukemiaMatthew S Davids, Jan A Burger
Pageof 23